What does Feng Chi Biotech Corp. do?

Feng Chi Biotech Corp. (6744.TWO) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 6744.TWO's market cap?

Feng Chi Biotech Corp. (6744.TWO) has a market capitalization of approximately $218.7 million, as of August 28, 2026, based on the most recent share price and shares outstanding.

Does 6744.TWO pay a dividend?

Yes — Feng Chi Biotech Corp. (6744.TWO) pays a dividend annually, with a trailing-twelve-month yield of 5.92%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.

6744.TWO

Feng Chi Biotech Corp.

TWO·Biotechnology · Healthcare

NT$14.20NT$0.10−0.70%

Market capNT$218.68M·Aug 28 3:31 AM UTC

Price Chart

NT$14.20−NT$0.10 (−0.70%)today

−47.31%CAGR −12.04%

Select date range

FromTo

Sep 25, 2019Aug 28, 2021 → Aug 28, 2026· 5.0 yrsAug 28, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)5.92%

Annual Dividend (FWD)NT$0.84

Dividend Growth (5Y)—

Dividend Safety—

Payout Ratio89.4%

FCF Payout Ratio792.2%

Most Recent DividendNT$0.840

Ex-Dividend DateJul 21

Payment DateAug 10

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)−36.6%

EPS Growth (3Y)−25.7%

EPS Growth (5Y)−16.4%

Next Earnings Date—

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

FinancialsFinancials Tab

RevenueNT$156.99M

Net IncomeNT$9.91M

Net Margin6.3%

Operating Cash FlowNT$2.42M

Capital ExpendituresNT$803.00K

Free Cash FlowNT$1.62M

Return on Equity4.3%

Return on Invested Capital1.2%

Net CashNT$167.81M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 6744.TWO and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 6744.TWO's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 6744.TWO and 80,000+ other tickers.

About Feng Chi Biotech Corp.

Feng Chi Biotech Corp., a company based in Taipei, Taiwan, specializes in offering a diverse range of diagnostic and scientific services. Their core activities encompass genetic screening for both pre-implantation and prenatal stages, comprehensive life science support, and early detection screening for newborns. Additionally, they perform microbiological assessments for the food and pharmaceutical sectors, alongside engaging in medical translational research. The company also acts as a supplier for various genetic testing technologies and products specifically tailored for the field of oncology.

CEO: Hong-Ming Zhang
Sector: Healthcare
Industry: Biotechnology
Exchange: TWO
Employees: 32
Website: www.fcbiotech.com.tw

Peers

Peers Tab

6848.TWO

RBC Bioscience Corporation

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 6744.TWO

What does Feng Chi Biotech Corp. do?: Feng Chi Biotech Corp. (6744.TWO) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 6744.TWO's market cap?: Feng Chi Biotech Corp. (6744.TWO) has a market capitalization of approximately $218.7 million, as of August 28, 2026, based on the most recent share price and shares outstanding.
Does 6744.TWO pay a dividend?: Yes — Feng Chi Biotech Corp. (6744.TWO) pays a dividend annually, with a trailing-twelve-month yield of 5.92%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.